retatrutide clinical trial brazil Medscape | The investigational triple GLP-1/GIP/glucagon receptor agonist produced significant weight loss and A1c reduction in people Nearly 30% average weight loss

The MHRA dismantled UK-based illicit manufacturing operations producing fake retatrutide and tirzepatide pens in October 2025 and February 2026

In a phase 2 clinical trial targeting obese individuals without type 2 diabetes (T2D), retatrutide dosed at 1 to 12 mg resulted in up to 24.2% weight loss over a 48-week treatment period, compared to 2.1% in the placebo group, and demonstrated a dose-dependent effect

Receive your prescription : If approved, the provider will prescribe Semaglutide or Tirzepatide , and your medications will be shipped directly to your home in cold-packed containers

I just may always be bigger than what society says average is, which I'm okay with

[DOI] [PubMed] [Google Scholar] 110.US House of Representatives